🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study evaluates the safety of different doses of a new medicine called ...
Status
Recruiting
Location
N America Res Inst - San Dimas
Start Date
2024-12-02
Trial ID
NCT06717698
Treatments Being Tested
NNC0519-0130 is a new medicine which may possibly help participants with ty...
Status
Completed
Location
SOUSEIKAI Sumida Hospital
Start Date
2023-05-15
Trial ID
NCT05870670
Treatments Being Tested
This study will look into a new study medicine called NNC0519-0130 to impro...
Status
Completed
Location
ICON
Start Date
2024-10-15
Trial ID
NCT06642571
Treatments Being Tested
This study will look at how a new medicine called NNC0519-0130 helps people...
Status
Completed
Location
Centricity Research-Arizona
Start Date
2024-03-18
Trial ID
NCT06326060
Treatments Being Tested
Novo Nordisk is developing a new study medicine NNC0519-0130 to improve the...
Status
Completed
Location
Peking University Third Hospital, Northern Branch-Phase I
Start Date
2025-05-26
Trial ID
NCT07004322
Treatments Being Tested
A new study medicine called NNC0519-0130 to improve treatment options for p...
Status
Completed
Location
Parexel International GmbH
Start Date
2024-08-07
Trial ID
NCT06567041
Treatments Being Tested
Novo Nordisk is developing a new study medicine NNC0519-0130 to improve the...
Status
Completed
Location
Medical University of Graz
Start Date
2024-11-20
Trial ID
NCT06718998
Treatments Being Tested
The purpose of the study is to investigate if NNC0519-0130 affects the bloo...
Status
Completed
Location
Parexel International GmbH
Start Date
2024-07-18
Trial ID
NCT06513104
Treatments Being Tested
NNC0519-0130 is a new medicine which may possibly help participants with ty...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2022-04-20
Trial ID
NCT05363774
Treatments Being Tested
NNC0519-0130 is a new medicine to improve the treatment options for people ...
Status
Completed
Location
Charité - Campus Charité Mitte - Charité Research Organisation GmbH
Start Date
2024-04-15
Trial ID
NCT06370819
Treatments Being Tested